High rates of cefiderocol plasma target attainment: results of a retrospective cohort study in 31 critically ill ICU patients

Affiliations

• ¹ Institute of Clinical Microbiology, Infectious Diseases and Infection Control, Nuremberg General Hospital, Paracelsus Medical University, Nuremberg, Germany.
• ² Intensive Care Unit, Department of Medicine 1, University Hospital Carl Gustav Carus, TU, Dresden, Dresden, Germany.
• ³ Institute for Biomedical and Pharmaceutical Research, Nuremberg-Heroldsberg, Germany.
• ⁴ Study Program in Human Medicine, Paracelsus Medical University, Nuremberg, Germany.
• ⁵ Institute of Pharmacology, West German Heart and Vascular Centre, University of Duisburg-Essen, Essen, Germany.
• ⁶ Institute of Clinical Microbiology, Infectious Diseases and Infection Control, Nuremberg General Hospital, Paracelsus Medical University, Nuremberg, Germany. ralph.bertram@klinikum-nuernberg.de.
• ⁷ Institute of Clinical Microbiology, Infectious Diseases and Infection Control, Nuremberg General Hospital, Paracelsus Medical University, Nuremberg, Germany. joerg.steinmann@klinikum-nuernberg.de.